Cargando…

Prevalence of COVID-19 outcomes in patients referred to opioid agonist treatment centers

Background: Coronavirus disease (COVID-19) is a mild to severe infectious respiratory illness caused by the SARS-CoV-2 virus. Based on the numerous pieces of evidence regarding the role of opioids in immune function, viral replication, and virus-mediated pathology, we decided to assess the incidence...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khani, Samira, Tafaroji, Javad, Yaghoubi, Mehdi, Emami Kazemabad, Mohammad Javad, Hejazi, Seyed Amir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076798/ https://www.ncbi.nlm.nih.gov/pubmed/37033605 http://dx.doi.org/10.3389/fphar.2023.1105176

Ejemplares similares

Comparative study of magnesium, sodium valproate, and concurrent magnesium-sodium valproate therapy in the prevention of migraine headaches: a randomized controlled double-blind trial
por: Khani, Samira, et al.
Publicado: (2021)

μ-opioid receptor agonists and psychedelics: pharmacological opportunities and challenges
por: Salinsky, Leah M., et al.
Publicado: (2023)

Transition From Full Mu Opioid Agonists to Buprenorphine in Opioid Dependent Patients—A Critical Review
por: Soyka, Michael
Publicado: (2021)

Prevalence of enteric adenovirus and co-infection with rotavirus in children under 15 years of age with gastroenteritis in Qom, Iran
por: Shams, Saeed, et al.
Publicado: (2022)

Desmetramadol Is Identified as a G-Protein Biased µ Opioid Receptor Agonist
por: Zebala, John A., et al.
Publicado: (2020)

Quantitative proteomic analysis reveals the effects of mu opioid agonists on HT22 cells
por: Zhang, Xutong, et al.
Publicado: (2023)

Exploration of beta-arrestin isoform signaling pathways in delta opioid receptor agonist-induced convulsions
por: Blaine, Arryn T., et al.
Publicado: (2022)

Design and development of novel, short, stable dynorphin-based opioid agonists for safer analgesic therapy
por: Lohman, Rink-Jan, et al.
Publicado: (2023)

Treatment With the Delta Opioid Agonist UFP-512 Alleviates Chronic Inflammatory and Neuropathic Pain: Mechanisms Implicated
por: Polo, Sara, et al.
Publicado: (2019)

Sex Differences in Kappa Opioid Receptor Agonist Mediated Attenuation of Chemotherapy-Induced Neuropathic Pain in Mice
por: Paton, Kelly F., et al.
Publicado: (2022)

Subacute toxicity evaluations of LPM3480392 in rats, a full µ-opioid receptor biased agonist
por: Ye, Liang, et al.
Publicado: (2023)

Agonist-Promoted Phosphorylation and Internalization of the Kappa Opioid Receptor in Mouse Brains: Lack of Connection With Conditioned Place Aversion
por: Chen, Chongguang, et al.
Publicado: (2022)

Mu-Opioid Receptor Agonist Induces Kir3 Currents in Mouse Peripheral Sensory Neurons – Effects of Nerve Injury
por: Stötzner, Philip, et al.
Publicado: (2018)

Identification of a potent dual-function inhibitor for hIMPDH isoforms by computer-aided drug discovery approaches
por: Yazdani, Meysam, et al.
Publicado: (2022)

Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders
por: Butelman, Eduardo R., et al.
Publicado: (2015)

Antinociceptive and Antipruritic Effects of HSK21542, a Peripherally-Restricted Kappa Opioid Receptor Agonist, in Animal Models of Pain and Itch
por: Wang, Xin, et al.
Publicado: (2021)

Modulation of Morphine Analgesia, Antinociceptive Tolerance, and Mu-Opioid Receptor Binding by the Cannabinoid CB2 Receptor Agonist O-1966
por: Reichenbach, Zachary W., et al.
Publicado: (2022)

Detection and characterization of rotavirus G and P types from children with acute gastroenteritis in Qom, central Iran
por: Shams, Saeed, et al.
Publicado: (2020)

Abuse Potential and Pharmacodynamic Characteristics of Oral and Intranasal Eluxadoline, a Mixed μ- and κ-Opioid Receptor Agonist and δ-Opioid Receptor Antagonist
por: Levy-Cooperman, N., et al.
Publicado: (2016)

Corrigendum: Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders
por: Butelman, Eduardo R., et al.
Publicado: (2015)

Prevalence of Helicobacter Pylori-Negative, Non-Steroidal Anti-Inflammatory Drug Related Peptic Ulcer Disease in Patients Referred to Afzalipour Hospital
por: Seyed Mirzaei, Seyed Mahdi, et al.
Publicado: (2015)

Editorial: Opioids and opioid-use disorders
por: de Guglielmo, Giordano, et al.
Publicado: (2023)

Comparison of Rifabutin-Based Versus Rifampin-Based Regimens for the Treatment of Mycobacterium avium Complex: A meta-Analysis Study
por: Hajikhani, Bahareh, et al.
Publicado: (2021)

Development of a novel cell-based, In-Cell Western/ERK assay system for the high-throughput screening of agonists acting on the delta-opioid receptor
por: Asghar, Junaid, et al.
Publicado: (2022)

Prevalence of Narcotic Bowel Syndrome in Opioid Abusers in Iran
por: Ahmadi, Bizhan, et al.
Publicado: (2014)

Demographic Evaluation of Oro-Dental Self-Injury for Insurance Deception; Evaluation of the Cases Referred to Shiraz Forensic Medicine Center
por: Shokouhi, Mohammad Mehdi, et al.
Publicado: (2019)

In vitro and in vivo Pharmacological Activities of 14-O-Phenylpropyloxymorphone, a Potent Mixed Mu/Delta/Kappa-Opioid Receptor Agonist With Reduced Constipation in Mice
por: Lattanzi, Roberta, et al.
Publicado: (2018)

Buprenorphine exposure levels to optimize treatment outcomes in opioid use disorder
por: Laffont, Celine M., et al.
Publicado: (2022)

Differential Patterns of Adherence to Opioid Therapy in Opioid Naïve and Opioid Existing Patients With Different Age Groups
por: Zin, Che Suraya, et al.
Publicado: (2019)

Neuroplasticity of the extended amygdala in opioid withdrawal and prolonged opioid abstinence
por: Kaplan, Gary B., et al.
Publicado: (2023)

The Effect of Transcranial Direct Current Stimulation on Relapse, Anxiety, and Depression in Patients With Opioid Dependence Under Methadone Maintenance Treatment: A Pilot Study
por: Sadeghi Bimorgh, Mohammad, et al.
Publicado: (2020)

Prevalence of alcohol consumption among clients of opioid agonist treatment (OAT) centers in Golestan province, Iran
por: Noroozi, Alireza, et al.
Publicado: (2023)

The effects of naltrexone on retention in treatment and being opioid-free in opioid-dependent people: A systematic review and meta-analysis
por: Zangiabadian, Moein, et al.
Publicado: (2022)

GLP-1 Receptor Agonists in Diabetic Kidney Disease: From Clinical Outcomes to Mechanisms
por: Kawanami, Daiji, et al.
Publicado: (2020)

Goofballing of Opioid and Methamphetamine: The Science Behind the Deadly Cocktail
por: Hazani, Hanis Mohammad, et al.
Publicado: (2022)

Intraoperative use of remifentanil and opioid induced hyperalgesia/acute opioid tolerance: systematic review
por: Kim, Sang Hun, et al.
Publicado: (2014)

Opioid use in the era of COVID-19: a multifaceted study of the opioid epidemic in Canada
por: Hutchinson, Molly, et al.
Publicado: (2023)

Virtual opioid agonist treatment: Alberta’s virtual opioid dependency program and outcomes
por: Day, Nathaniel, et al.
Publicado: (2022)

Prevalence of Therapeutic use of Opioids in Chronic non-Cancer Pain Patients and Associated Factors: A Systematic Review and Meta-Analysis
por: De Sola, Helena, et al.
Publicado: (2020)

Prevalence of intestinal parasites in referred individuals to the medical centers of Tonekabon city, Mazandaran province
por: Shahdoust, Samira, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_09eq0808im63hv9up6dffmca19